Page 1 of 17 Transcript of FDA’s Media Briefing on the Approval of Truvada for Pre-Exposure Prophylaxis (PrEP) Moderator: Erica Jefferson July 16, 2012

First Page		Document Content
Health Microbiology Pre-exposure prophylaxis IPrEx Tenofovir/emtricitabine Antiretroviral drug Emtricitabine AIDS HIV Gilead Sciences Medicine HIV/AIDS		Page 1 of 17 Transcript of FDA’s Media Briefing on the Approval of Truvada for Pre-Exposure Prophylaxis (PrEP) Moderator: Erica Jefferson July 16, 2012 Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 42,27 KB Share Document on Facebook

	PDF Document DocID: 1xRXL - View Document
	PDF Document DocID: 1xQkg - View Document
	PDF Document DocID: 1xQ5g - View Document
	PDF Document DocID: 1xLM9 - View Document
	PDF Document DocID: 1xKA5 - View Document